The opioid crisis has resulted in an increase in hepatitis C virus (HCV) prevalence among persons of reproductive age, including pregnant persons.  There have been significant recent changes in the screening and treatment strategies for HCV due to the advent of highly effective and well tolerated direct acting antiviral medications.  In this webinar, the current HCV screening and management recommendations for pregnant persons will be reviewed.  In addition, best practices for postpartum HCV care linkage will be presented.  The data to date for HCV treatment in pregnancy with sofosbuvir-based regimens will also be discussed.

1. Describe the screening and management of HCV during pregnancy. 
2. List the consequences of HCV during pregnancy for both the pregnant person and their infant.
3. Outline the data to date for the safety and efficacy of HCV treatments in pregnancy.
4. Apply best practices for postpartum linkage to HCV care.

ACCREDITATION:
This actvity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association and The American Osteopathic Academy of Addiction Medicine (AOAAM). The American Osteopathic Association is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT HOURS:
The American Osteopathic Association designates this other activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.